Abstract:For both in situ or ex situ regeneration of tissues to be repaired,an ideal tissue engineering scaffold should create a local environment to facilitate homing,induced differentiation,and proliferation in addition to its molding function.For a tissue engineering scaffold to achieve this objective,releasing the relevant cell growth factors for sufficient period of time is more efficient and natural over that by material morphology.However,protein drugs are delicate and easily denatured by the harsh conditions of preparation for tissue engineering scaffolds,which may evoke undesirable antibody responses.None of the tissue engineering scaffolds reported to date have achieved long-term sustained-release of cell growth factor proteins in native conformation.To overcome this still-standing hurdle,the present study demonstrated a method to load cytokine proteins into tissue-engineering fibers with preserved native conformation for achieving long term sustained-release.We first preloaded vascular endothelial growth factor (VEGF165) as the model protein into dextran nanoparticles without contacting water-oil or water-gas interface (recognized protein conformation killer) by utilizingthe freezing induced aqueous phase separation method developed in our lab.Then the VEGF165 protected in the matrix of dextran particles were suspended in a solution of poly (lactic-co-glycolic acid) (PLGA) prior to electrospinning to form fibers.In order to avoid burst release in the initial stage by the protein-preloaded particles exposed at the fiber surface,another layer of PLGA fiber which carried no VEGF165 was spanned on the top of the already formed PLGA fiber membrane.A series of physicochemical characterizations comprising scanning electron microscopy (SEM),contact angle,mechanical strength,confirmed that the tissue engineering fibers formed above possessed satisfied surface texture and mechanical strength.The VEGF165 was recovered after each of the preparation step and assayed using CCK-8 test for bioactivity.The results indicated that the VEGF165 recovered from the dextran nanoparticles retained＞97 ％ bioactivity,and that from the final fiber was above 87 ％,both were remarkably higher than that recovered from the fibers formed in which the protein was preloaded in solution form (＜55 ％).In vitro release test showed that nanoparticles composite fibers prepared as above achieved a sustained-release profile with minimal initial burst and un-released residue.The protein was released less than 35 ％ of the total load in the initial five days and over 92％ at day 25.For the fibers wherein VEGF16s was loaded in the solution form,the 53.12 ％ of protein load was released in the initial five days,and 84.52 ％ was released at day 25.The therapeutic efficacy of the VEGF165 loaded fiber membranes were examined on the rat model of lowerlimb ischemia,followed immunohistochemistry observation.The results indicated that the regenerated blood vessels by dextran nanoparticles composite PLGA fibers were significantly more than that by the fibers to which VEGF165 was loaded in solution form.As conclusion,pre-loading proteins in polysaccharide nanoparticles prior to electrospinning was an effective method to prepare efficacious tissue engineere fibers for sustained-release cell growth factored with preserved bioactivity and improved release kinetics.

Electrospun Polylactic Acid/sulfadiazine Sodium/proteinase Nanofibers and Their Applications in Treating Frostbite

Silk Fibroin/poly-(L-lactide-co-caprolactone) Nanofiber Scaffolds Loaded with Huangbai Liniment to Accelerate Diabetic Wound Healing

Novel SA@Ca2+/RCSPs Core–shell Structure Nanofibers by Electrospinning for Wound Dressings

Pharmacodynamic study: Astragaloside IV/chitosan/polylactic acid composite electrospinning scaffold for wound healing in diabetic rats

In Vitro and In Vivo Comparison Study of Electrospun PLA and PLA/PVA/SA Fiber Membranes for Wound Healing

Preclinical animal study of electrospun poly (l-lactide-co-caprolactone) and formulated porcine fibrinogen for full-thickness diabetic wound regeneration

Electrospun Hierarchical Structural Films for Effective Wound Healing

Preparation and Protein Sustained-release System of Electrospinning Nanofibers

Integration of Zn2+, ATP, and bFGF to Nanodressing with Core-Shell Structure Fabricated by Emulsion Electrospinning for Wound Healing

Application of Electrospun Nanofiber Membrane in the Treatment of Diabetic Wounds

Astragaloside/PVP/PLA nanofiber functional dressing prepared by coaxial electrostatic spinning technology for promoting diabetic wound healing

Poly (lactic acid) electrospun nanofiber membranes: Advanced characterization for biomedical applications with drug loading performance studies

In vivo wound healing and antibacterial performances of electrospun nanofibre membranes

Preparation and Characterization of Novel Multifunctional Wound Dressing by Near-Field Direct-Writing Electrospinning and Its Application

Preparation of nanocomposite membranes loaded with taxifolin liposome and its mechanism of wound healing in diabetic mice

Electrospun Fenoprofen/Polycaprolactone @ Tranexamic Acid/Hydroxyapatite Nanofibers as Orthopedic Hemostasis Dressings

Electrospun nanofibers as a wound dressing for treating diabetic foot ulcer

An Injectable Bioactive Dressing Based on Platelet-Rich Plasma and Nanoclay: Sustained Release of Deferoxamine to Accelerate Chronic Wound Healing

Cross-Linked Electrospun pH-Sensitive Nanofibers Adsorbed with Temporin-Ra for Promoting Wound Healing

Dual bio-active factors with adhesion function modified electrospun fibrous scaffold for skin wound and infections therapeutics

Electrospun multifunctional nanofibrous mats loaded with bioactive anemoside B4 for accelerated wound healing in diabetic mice